Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Burning Rock Biotech Ltd. (BNR)
NASDAQ:BNR
Burning Rock Biotech (BNR) Stock Price & Analysis
67 Followers
BNR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.70 - $4.24
Previous Close$2.42
Volume159.44K
Average Volume (3M)59.63K
Market Cap
$248.40M
Enterprise Value-$626.08M
Total Cash (Recent Filing)¥925.27M
Total Debt (Recent Filing)¥50.79M
Price to Earnings (P/E)-1.9
Beta1.86
Next Earnings
Aug 30, 2023EPS Estimate
-$0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.26
Shares Outstanding82,330,000
10 Day Avg. Volume49,694
30 Day Avg. Volume59,634
Standard Deviation0.22
R-Squared0.00202
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.19
Price to Sales (P/S)0.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$8.90Price Target Upside267.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Burning Rock Biotech News
Press ReleasesBurning Rock Publishes 2022 Annual Report on Form 20-F
Press ReleasesBurning Rock provides an update on 2022 revenue guidance
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BNR FAQ
What was Burning Rock Biotech Ltd.’s price range in the past 12 months?
Burning Rock Biotech Ltd. lowest stock price was $1.70 and its highest was $4.24 in the past 12 months.
What is Burning Rock Biotech Ltd.’s market cap?
Currently, no data Available
When is Burning Rock Biotech Ltd.’s upcoming earnings report date?
Burning Rock Biotech Ltd.’s upcoming earnings report date is Aug 30, 2023 which is in 88 days.
How were Burning Rock Biotech Ltd.’s earnings last quarter?
Burning Rock Biotech Ltd. released its earnings results on May 30, 2023. The company reported -$0.255 earnings per share for the quarter, missing the consensus estimate of -$0.196 by -$0.059.
Is Burning Rock Biotech Ltd. overvalued?
According to Wall Street analysts Burning Rock Biotech Ltd.’s price is currently Undervalued.
Does Burning Rock Biotech Ltd. pay dividends?
Burning Rock Biotech Ltd. does not currently pay dividends.
What is Burning Rock Biotech Ltd.’s EPS estimate?
Burning Rock Biotech Ltd.’s EPS estimate is -$0.19.
How many shares outstanding does Burning Rock Biotech Ltd. have?
Burning Rock Biotech Ltd. has 82,327,410 shares outstanding.
What happened to Burning Rock Biotech Ltd.’s price movement after its last earnings report?
Burning Rock Biotech Ltd. reported an EPS of -$0.255 in its last earnings report, missing expectations of -$0.196. Following the earnings report the stock price went up 2.632%.
Which hedge fund is a major shareholder of Burning Rock Biotech Ltd.?
Among the largest hedge funds holding Burning Rock Biotech Ltd.’s share is Bridgewater Associates, LP. It holds Burning Rock Biotech Ltd.’s shares valued at 182K.
---
Burning Rock Biotech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.90 (267.77% Upside)
$8.90 (267.77% Upside)
Hedge Fund Trend
Decreased
By 20.5K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.68%
12-Months-Change
Fundamentals
Return on Equity
-63.38%
Trailing 12-Months
Asset Growth
-37.93%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Burning Rock Biotech Ltd.
Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and LungPlasma. The company has developed various cancer detection products , involving tumor targeting, oncomitant diagnosis of immune drugs, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress and detection of tumor sensitivity.
---
Top 5 ETFs holding BNR
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold BNR. The ETFs are listed according to market value of BNR within the ETF
---
---